These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

566 related articles for article (PubMed ID: 315413)

  • 41. Thrombin-generating capacity in patients with von Willebrand's disease.
    Rugeri L; Beguin S; Hemker C; Bordet JC; Fleury R; Chatard B; Negrier C; Dargaud Y
    Haematologica; 2007 Dec; 92(12):1639-46. PubMed ID: 18055987
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.
    Weiss HJ; Rogers J; Brand H
    J Clin Invest; 1973 Nov; 52(11):2697-707. PubMed ID: 4201262
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasma collagen cofactor correlates with von Willebrand factor antigen and ristocetin cofactor but not with bleeding time.
    Aihara M; Kimura A; Chiba Y; Yoshida Y
    Thromb Haemost; 1988 Jun; 59(3):485-90. PubMed ID: 3142084
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets.
    Ruggeri ZM; Zimmerman TS
    J Clin Invest; 1980 Jun; 65(6):1318-25. PubMed ID: 6773982
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Von Willebrand's syndrome (author's transl)].
    Larrieu MJ; Meyer D; Ardaillou N
    Nouv Rev Fr Hematol Blood Cells; 1977; 18(2):371-82. PubMed ID: 303357
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pseudo-von Willebrand's disease.
    Hoyer LW
    N Engl J Med; 1982 Feb; 306(6):360-2. PubMed ID: 6798443
    [No Abstract]   [Full Text] [Related]  

  • 47. Carbohydrate deficiency of the factor VIII/von Willebrand factor Protein in von Willebrand's disease variants.
    Gralnick HR; Coller BS; Sultan Y
    Science; 1976 Apr; 192(4234):56-9. PubMed ID: 1083071
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multimeric composition of factor VIII/von Willebrand factor following administration of DDAVP: implications for pathophysiology and therapy of von Willebrand's disease subtypes.
    Ruggeri ZM; Mannucci PM; Lombardi R; Federici AB; Zimmerman TS
    Blood; 1982 Jun; 59(6):1272-8. PubMed ID: 6805532
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evidence that the platelet retention factor is separate from the factor VIII-related antigen and factor VIII.
    Rubin H; Alter AA; Walker MR; Stefanyshyn M; Scott L; Miotti AB
    J Lab Clin Med; 1976 Jul; 88(1):14-21. PubMed ID: 180215
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Variant forms of von Willebrand's disease: type IIA, type IIB and platelet-type von Willebrand's disease.
    Takahashi H
    Nihon Ketsueki Gakkai Zasshi; 1984 Dec; 47(8):1678-89. PubMed ID: 6335811
    [No Abstract]   [Full Text] [Related]  

  • 51. The role of the spleen in regulating the plasma levels of factor VIII--von Willebrand's factor after DDAVP.
    Garcia VV; Coppola R; Mannucci PM
    Blood; 1982 Dec; 60(6):1402-6. PubMed ID: 6814552
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Von Willebrand factor multimer patterns in von Willebrand's disease.
    Hoyer LW; Rizza CR; Tuddenham EG; Carta CA; Armitage H; Rotblat F
    Br J Haematol; 1983 Nov; 55(3):493-507. PubMed ID: 6416288
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Telangiectasia and von Willebrand's disease in two families.
    Conlon CL; Weinger RS; Cimo PL; Moake JL; Olson JD
    Ann Intern Med; 1978 Dec; 89(6):921-4. PubMed ID: 309746
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The use of monoclonal antibodies in measuring factor VIII/von Willebrand factor.
    Lamme S; Wallmark A; Holmberg L; Nilsson IM; Sjögren HO
    Scand J Clin Lab Invest; 1985 Feb; 45(1):17-26. PubMed ID: 3919440
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Studies on the pathophysiology and treatment of von Willebrand's disease. VI. Variant von Willebrand's disease complicating placenta previa.
    Takahashi H
    Thromb Res; 1983 Jul; 31(2):285-96. PubMed ID: 6605595
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Studies on the pathophysiology and treatment of von Willebrand's disease. II. Gel filtration studies on plasma factor VIII in von Willebrand's disease.
    Takahashi H
    Nihon Ketsueki Gakkai Zasshi; 1981 Feb; 44(1):165-72. PubMed ID: 6797214
    [No Abstract]   [Full Text] [Related]  

  • 57. Absence of a bleeding tendency in severe acquired von Willebrand's disease. The role of platelet von Willebrand factor in maintaining normal hemostasis.
    Drouin J; Lillicrap DP; Izaguirre CA; Sutherland M; Windsor S; Benford K; Hoogendorn H; Giles AR
    Am J Clin Pathol; 1989 Oct; 92(4):471-8. PubMed ID: 2508465
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An electroblotting technique for the detection of factor VIII/von Willebrand factor multimers in plasma.
    Furlong BL; Peake IR
    Br J Haematol; 1983 Apr; 53(4):641-53. PubMed ID: 6403025
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of inhibitory and binding characteristics of an antibody causing acquired von Willebrand syndrome: an assay for von Willebrand factor binding by antibody.
    Fricke WA; Brinkhous KM; Garris JB; Roberts HR
    Blood; 1985 Sep; 66(3):562-9. PubMed ID: 3927998
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differentiation of patients with subtype IIb-like von Willebrand's disease by means of perfusion experiments with reconstituted blood.
    Sakariassen KS; Nieuwenhuis HK; Sixma JJ
    Br J Haematol; 1985 Mar; 59(3):459-70. PubMed ID: 3918560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.